← Back to Search

Behavioural Intervention

Cognitive Training for Social Anxiety Disorder

N/A
Recruiting
Led By Han-Joo Lee, PhD
Research Sponsored by University of Wisconsin, Milwaukee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of social anxiety disorder (based on the DIAMOND interview - Social anxiety module)
Moderate or severe symptoms of social anxiety as revealed by the Liebowitz Social Anxiety Scale (LSAS score of ≥ 40) or MINI-SPIN (Score of ≥ 6)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-training (before the first mobile training), post-training (after three weeks of training), 2-week follow-up (two weeks after the post training assessment)
Awards & highlights

Study Summary

This trial looks at ways to improve a cognitive training method for people with social anxiety. It will assess if this training can help shift their attention away from threat stimuli and toward neutral stimuli.

Who is the study for?
This trial is for adults aged 18-60 with social anxiety disorder, confirmed by a specific interview and scoring high on anxiety scales. Participants must speak English as their primary language and have access to a mobile device to use the training app.Check my eligibility
What is being tested?
The study tests an improved Attentional Bias Modification Training (ABMT) designed to help people with social anxiety shift focus from threatening to neutral stimuli. It compares active ABMT against placebo over three weeks, measuring changes in attention patterns before and after training.See study design
What are the potential side effects?
Since ABMT involves cognitive exercises on a mobile app without medication or invasive procedures, significant side effects are not expected. However, participants may experience discomfort or frustration if they find the tasks challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with social anxiety disorder.
Select...
I have moderate to severe social anxiety.
Select...
I am between 18 and 60 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-training (before the first mobile training), post-training (after three weeks of training), 2-week follow-up (two weeks after the post training assessment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-training (before the first mobile training), post-training (after three weeks of training), 2-week follow-up (two weeks after the post training assessment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Mini-Social Phobia Inventory (Mini-SPIN) across Pre-training, Post-training, and 2-week follow up
Secondary outcome measures
Change in Depression, Anxiety, and Stress Scale (DASS-21) across Pre-training, Post-training, and 2-week follow-up
Change in Liebowitz Social Anxiety Scale (LSAS-SR) across Pre-training, Post-training, and 2-week follow-up

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Integrated ABM (I-ABM)Active Control1 Intervention
The I-ABM will include four progressively difficult levels of training blocks, each containing 72 trials. Participants will be required to tap or swipe the probe in the correct direction during the first and second levels of training. The inhibitory control components will be included in the third and fourth levels, where participants should not respond to the probe under certain conditions. Each training will take 10-15 minutes, and participants will complete the sessions three times a week for three weeks.
Group II: Placebo Training (PLT)Placebo Group1 Intervention
The PLT has four training blocks that follow the same basic design as the I-ABM training. However, the PLT will not aim to change social anxiety-related attention bias. Participants will simply swipe or tap the probe regardless of the stimuli condition, which is expected to exert a minimum level of effect on changing the attention bias linked to social anxiety. Participants will complete the training three times per week for three weeks.

Find a Location

Who is running the clinical trial?

University of Wisconsin, MilwaukeeLead Sponsor
49 Previous Clinical Trials
6,573 Total Patients Enrolled
Han-Joo Lee, PhDPrincipal Investigator414-229-5858

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial extend to adults aged sixty and above?

"This research is searching for individuals aged 18 and older, but below the age of 60."

Answered by AI

Is the recruitment phase of this trial still underway?

"Indeed, according to the online information found on clinicaltrials.gov, this research endeavour is still searching for participants. It was first published on April 7th 2022 and was recently modified on September 19th 2023."

Answered by AI

Could I potentially join this scientific research endeavor?

"Participants must have been diagnosed with social anxiety disorder and be in the eligible age range of 18 to 60 years old in order to qualify for this medical trial. Approximately sixty individuals will take part."

Answered by AI

How many individuals is the current clinical research examining?

"Affirmative. The clinical trial registry hosted on clinicaltrials.gov reveals that this study, initiated on April 7th 2022, is actively recruiting participants. 60 individuals are being sought from one medical centre."

Answered by AI
~9 spots leftby Aug 2024